Mumbai-based Lupin has launched Doxycycline for Injection USP, a generic version of Pfizer's Vibramycin, and received USFDA approval for Letermovir Tablets, merging them into the competitive US market. These moves demonstrate Lupin's commitment to providing cost-effective solutions in treating bacterial infections and cytomegalovirus diseases.
